Pulling SEC filings + quote and writing the call…

DNA X, Inc.
Next earnings Aug 6, 2026
Last earnings +4.2% on 2026-05-20
Going-concern shell that sold its only real business and bet the remains on an unproven crypto platform — negative equity, near-empty till.
Cash & equivalents $1.30M · FY2025
This is not the company its P/S of 0.1 implies. The revenue history ($50.9M FY2024, down 45.6%) belongs entirely to the legacy Sonim phone/hotspot business, which management sold to Pace Car Acquisition LLC in January 2026 for $15M and now reports as a discontinued operation for all periods. What remains is DNA X, a cryptocurrency trading platform acquired December 15, 2025 that only became operational in November 2025 — so the 'company' you are buying has essentially no revenue track record, and the cheap-looking sales multiple is an artifact of businesses that no longer exist. The filing is blunt: 'there is substantial doubt regarding the Company's ability to continue as a going concern.'
The balance sheet corroborates the warning. Stockholders' equity is negative $7.96M against a $304M accumulated deficit; cash fell 75.6% to just $1.30M while operating activities burned $23.5M in FY2025. Current liabilities ($48.0M) exceed current assets ($28.9M) by roughly $19M, and both current and long-term debt lines exploded (+3,345% and +1,299%). The company stayed alive only by selling stock — $13.7M via ATM and private placements plus $5.1M of promissory notes — and has a Chardan ChEF committed-equity facility standing by to sell still more. With 1.49M shares (post a 1-for-18 reverse split) and a $5.58M market cap, holders face relentless dilution against a $23.5M-a-year burn rate on a platform running 'on a limited basis.'
Is SONM a buy? The one-page verdict, explained →
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $54.6M | $69.8M | $93.6M | $50.9M | — |
| Gross profit | $6.41M | $11.6M | $19.3M | $9.92M | — |
| Operating income | -$38.0M | -$14.3M | $513K | -$3.10M | -$5.41M |
| Net income | -$38.6M | -$14.1M | -$90.0K | -$33.6M | -$20.7M |
| Diluted EPS | — | -$0.49 | -$0.02 | -$128.37 | -$28.58 |
| Net margin | -70.8% | -20.2% | -0.1% | -66.1% | — |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
New financing pact with unregistered share sale + charter changes to holder rights
Terminated a material definitive agreement
Nasdaq delisting notice plus new debt obligation and further unregistered share sales
Q1 10-Q: pivot to DNA X crypto trading, phone unit now discontinued operations
Q1 10-Q: pivot to DNA X crypto trading, phone unit now discontinued operations
Filed NT 10-Q late-filing notice for the Q1 quarterly report
Amended FY2025 10-K (10-K/A) to add omitted disclosures
Amended FY2025 10-K (10-K/A) to add omitted disclosures
FY2025 10-K flags going-concern doubt; sold phone unit, pivoted to crypto
Sources: SEC EDGAR (CIK 0001178697, latest 10-Q filed 2026-05-20) · EODHD · Proprietary analysis · as of 7/4/2026, 9:57:29 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 5:57 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-02-09 | Crolius Clayton Chief Financial Officer | Award | 35.0K | |
| 2026-02-09 | MULICA MICHAEL C Acting CEO | Award | 50.0K | |
| 2025-06-30 | LYTTON LAURENCE W 10% owner | Sell | 401K @ $1.39 | $557K |
| 2025-06-26 | LYTTON LAURENCE W 10% owner | Sell | 466K @ $1.50 | $700K |
| 2025-04-23 | Becher Charles See Remarks | Sell | 31.3K @ $1.45 | $45.4K |
| 2025-04-23 | MULICA MICHAEL C Director | Sell | 27.8K @ $1.45 | $40.3K |
| 2025-04-23 | Crolius Clayton Chief Financial Officer | Sell | 11.6K @ $1.45 | $16.9K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median